SGER: Cell Cultures, Institutional Cultures and the Regulatory Terrain-The Role of Stakeholders in the California Stem Cell Institute
SGER:细胞培养、机构文化和监管领域 - 利益相关者在加州干细胞研究所中的作用
基本信息
- 批准号:0647987
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-15 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
SGER: Cell Cultures, Institutional Cultures and the Regulatory Terrain - The Role of Stakeholders in the California Stem Cell InstituteSES-0647987, Project AbstractThis project will explore stakeholder roles in the California Institute for Regenerative Medicine (the Institute) from the time the California Research and Cures Initiative (Proposition 71) was introduced, to recognition of the Institute as a potentially viable, if fragile, research institution. This is a qualitative eighteen-month pilot study, which will take advantage of a real time laboratory to study the changing perceptions of stakeholders during the Institute's organizational period, and the impact of stakeholders on the framing of the Institute's governance, management and oversight infrastructure. It will be a "baseline" observation of an interesting and important organization, intended to serve as a precursor to a broader study examining the initial period of Institute development. The 2004 passage of the Initiative marked a turning point in the political history of scientific research in the United States. The Initiative codified stem cell research as a constitutional right of the people of California, and authorized three billion dollars in public state-issued bonds over 10 years, to fund stem cell research and facilities throughout the state. This is possibly the first time that a dedicated scientific institution has been created by a public ballot initiative. The intellectual merit of the project is based on recognition that the Initiative process and the Institute itself raise fundamental questions about the role of various publics in science: --How do stakeholders and stakeholder coalitions impact publicly funded research? --How should stakeholders be included in the Institute's organizational structure?--How has the Institute and its governing bodies responded to the demands of diverse stakeholders in key organizational areas such as ethical oversight, strategic planning and grant approval policies? The Initiative process brought a third party -- stakeholders-- into the existing dyadic relationship between scientific researchers and government regulators. This research will provide preliminary insight into how these concerns may affect implementation of the Initiative, although concrete answers will await further study. The specific objectives of the research are: (1) To identify the key stakeholder interest coalitions in Institute governance and oversight processes; (2) To identify stakeholder perceptions about key issues of stem cell research; and (3) To study which stakeholder groups have been most successful in achieving presence, influence and voice, and how that success has been achieved. We will collect two types of data: (1) semi-structured stakeholder interviews, and (2) documentary data from Institute and stakeholder organization archives. The data will address two dimensions of success: organizational success, e.g. whether specific objectives of the Initiative are met; and informal success; e.g. stakeholder perceptions of success. Data will assess the participation of stakeholders on the Institute's Oversight Committee and Working Groups, and the responses of the Oversight Committee and Working Groups to the stakeholders. Long-term impact involves the production of new knowledge regarding the broader theoretical issues of governance and oversight of scientific research. Another impact is the potential usefulness of these pilot data for a broader multi-disciplinary, longitudinal study of the continued evolution of the Institute's mechanisms for scientific governance and oversight, focusing on the roles of federal and state government and on the emergence of national stakeholders.
SGER:细胞培养、机构培养和监管地形-利益相关者在加州干细胞研究所的作用SES-0647987,项目摘要本项目将探讨利益相关者在加州再生医学研究所的作用从加州研究和治疗计划开始,(第71号提案),承认该研究所是一个潜在的可行的研究机构,如果脆弱的。这是一项为期18个月的定性试点研究,将利用一个真实的时间实验室,研究利益攸关方在研训所组建期间不断变化的看法,以及利益攸关方对研训所治理、管理和监督基础设施框架的影响。这将是对一个令人感兴趣和重要的组织的“基线”观察,旨在作为审查研训所发展初期的更广泛研究的先驱。2004年该倡议的通过标志着美国科学研究政治史上的一个转折点。该倡议将干细胞研究编纂为加州人民的宪法权利,并授权在10年内发行30亿美元的公共债券,为全州的干细胞研究和设施提供资金。这可能是第一次由公众投票倡议创建一个专门的科学机构。该项目的知识价值是基于这样一种认识,即倡议进程和研究所本身提出了关于各种公众在科学中的作用的基本问题:-利益攸关方和利益攸关方联盟如何影响公共资助的研究?--如何将利益攸关方纳入研究所的组织结构?研究所及其理事机构如何回应不同利益攸关方在关键领域的要求, 组织领域,如道德监督、战略规划和赠款审批政策?该倡议进程将第三方-利益攸关方-纳入科学研究人员与政府监管机构之间现有的二元关系。这项研究将使人们初步了解这些关切可能如何影响倡议的执行,但具体答案有待进一步研究。 该研究的具体目标是:(1)确定研究所治理和监督过程中的关键利益相关者利益联盟;(2)确定利益相关者对干细胞研究关键问题的看法;(3)研究哪些利益相关者群体在实现存在、影响力和发言权方面最成功,以及如何取得成功。我们将收集两种类型的数据:(1)半结构化的利益相关者访谈,以及(2)来自研究所和利益相关者组织档案的文件数据。这些数据将涉及成功的两个方面:组织上的成功,例如倡议的具体目标是否实现;以及非正式的成功,例如利益攸关方对成功的看法。数据将评估利益攸关方参与研训所监督委员会和工作组的情况,以及监督委员会和工作组对利益攸关方的回应。 长期影响包括产生关于科学研究的管理和监督的更广泛的理论问题的新知识。另一个影响是,这些试点数据可能有助于对研究所科学治理和监督机制的持续演变进行更广泛的多学科纵向研究,重点是联邦和州政府的作用以及国家利益攸关方的出现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joanna Weinberg其他文献
Invention and convention: Jewish and Christian critique of the Jewish fixed calendar
- DOI:
10.1023/a:1007196823678 - 发表时间:
2000-10-01 - 期刊:
- 影响因子:0.400
- 作者:
Joanna Weinberg - 通讯作者:
Joanna Weinberg
Poetry and patronage: Azariah de’ Rossi’s elegies for Margaret of Savoy
- DOI:
10.1007/s10835-006-9028-x - 发表时间:
2007-02-17 - 期刊:
- 影响因子:0.400
- 作者:
Joanna Weinberg - 通讯作者:
Joanna Weinberg
Early Modern Jewish Readers of Josephus
- DOI:
10.1007/s12138-016-0409-3 - 发表时间:
2016-07-14 - 期刊:
- 影响因子:0.200
- 作者:
Joanna Weinberg - 通讯作者:
Joanna Weinberg
Joanna Weinberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joanna Weinberg', 18)}}的其他基金
Johann Buxtorf 1 (1564-1629): A late Renaissance Student of Judaism
约翰·巴克托夫 1 (1564-1629):文艺复兴晚期的犹太教学生
- 批准号:
AH/J00118X/1 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Fellowship
相似国自然基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
- 批准号:QN25H220002
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
- 批准号:TGY24H080011
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
- 批准号:82305053
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向Cell-Free网络的协同虚拟化与动态传输
- 批准号:62371367
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
- 批准号:82373069
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
- 批准号:82273886
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
- 批准号:2021JJ30609
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker – in Monitoring Response and Recurrence of Bladder Cancer
尿癌细胞培养 (UCCC) 尿液样本分析前因素的评估——一种非侵入性生物标志物 — 用于监测膀胱癌的反应和复发
- 批准号:
10640606 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Replacing Mouse Immunotherapy Models with Human Colorectal Cancer Organoid - T Cell Cultures
用人结直肠癌类器官替代小鼠免疫治疗模型 - T 细胞培养物
- 批准号:
NC/X001326/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Training Grant
PFI-TT: Non-enzymatic harvesting of cell cultures
PFI-TT:细胞培养物的非酶收获
- 批准号:
2141138 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Standard Grant
Rapid high throughput cost effective evaluation of viral vector efficacy Rapid image pattern analysis microfluidic cell cultures using AI algorithms
快速高通量、经济有效地评估病毒载体功效 使用 AI 算法快速图像模式分析微流体细胞培养物
- 批准号:
BB/X511250/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Training Grant
Real time imaging system for cell and tissue cultures
用于细胞和组织培养的实时成像系统
- 批准号:
501903209 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Major Research Instrumentation
Determining the translational mechanisms that control cell fate during cell competition in human pluripotent stem cell cultures
确定人类多能干细胞培养物中细胞竞争过程中控制细胞命运的翻译机制
- 批准号:
MR/X503150/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
Automated high-resolution microscope platform with robotics to study pharmacodynamics in 3D cell cultures
具有机器人技术的自动化高分辨率显微镜平台,用于研究 3D 细胞培养物中的药效学
- 批准号:
MR/X013502/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
Identification of dendritic cells in olfactory lamellar cell cultures from rainbow trout
虹鳟鱼嗅层细胞培养物中树突状细胞的鉴定
- 批准号:
572031-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Towards rapid, high-throughput and cost-effective evaluation of viral vector efficacy: Rapid image pattern analysis from microfluidic cell cultures us
对病毒载体功效进行快速、高通量和具有成本效益的评估:使用微流体细胞培养物进行快速图像模式分析
- 批准号:
2747236 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship
Using ex vivo organotypic cultures to investigate donor cell integration in the gut
使用离体器官型培养物研究肠道中供体细胞的整合
- 批准号:
NC/V001078/1 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Research Grant